RZTO results important for organic artificial meat replacement industry

|

Published 17-DEC-2019 09:47 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Roots Sustainable Agricultural Technologies Limited (ASX:ROO) has provided a promising report on the first stage Proof of Concept (POC) study being conducted on the effects of its patented Root Zone Temperature Optimisation (RZTO) technology on protein-based model plants.

The roots of two protein-based model peas and beans plants were cooled by deploying RZTO.

Observations at the end of the summer growing cycle at Roots’ research and development facility in Bet Halevi, Israel, resulted in 57% to 67% more pods yield per plant for both the peas and beans when compared with uncooled plants.

Plant roots were cooled by the vertical RZTO ‘stab’, and horizontally by RZTO architecture respectively.

While protein percentage was slightly affected, total pods protein content increased by 77% and 55% in peas and beans respectively in cooled plants, when compared to uncooled plants.

Roots is encouraged by these results as the POC demonstrated that RZTO use resulted in weight increase per plant and more pods being generated per plant.

Benefits for commercial growers

The results achieved through the deployment of RZTO could have significant benefits if employed by growers in a commercial environment.

The protocol of the POC conducted at Roots’ facility was organic and used no fertiliser or other chemicals.

The company believes that this initiative will be of particular interest to the plant-based meat industry.

Roots is currently planting another cycle of beans and peas for the second stage of the POC growing cycle in an open field.

During this cycle, the plants will be heated using Roots’ technology throughout the coming winter.

The graph below illustrates that while outside measured temperatures peaked at more than 30 degrees, uncooled root zones peaked at 25 degrees, and cooled roots zones were never more than 19 degrees.

In discussing these promising developments, Roots chief executive Dr. Sharon Devir highlighted the positive implications for Roots participation in the high-end, organic artificial meat replacement industry in saying, “We are very encouraged by the results from this POC, conducted at our experimental farm, without the use of fertilisers, herbicides and pesticides using our proprietary RZTO technology.

‘’The results may support our hypothesis that by cooling roots using RZTO, the plant will increase the total pods yield and therefore, increase protein content.

‘’This is very promising for Roots as it pursues opportunities in the high end, organic artificial meat replacement industry which relies on industrially grown, high protein crops with heavy use of herbicides and pesticides.

‘’Our organic-based protein crops, free of chemicals, are thus likely to have broad appeal.

“The second stage of this important POC commences next month and we look forward to reporting on progress.

‘’This is indeed another positive development for the growing appeal of RZTO.’’



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X